Article and Video CATEGORIES

Cancer Journey

Search By

Ramy Sedhom, MD, is a Medical Oncology Fellow at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore, Maryland.

He is interested in Supportive and Palliative Care for patients across the cancer continuum - from a clinical, research, and policy perspective. Following his oncology training, he will be pursuing a clinical fellowship in Hospice and Palliative Care.

Androgen Deprivation Therapy (ADT) for Men with Prostate Cancer
dbrock
Supportive Care Video Series 2019
Author
Ramy Sedhom, MD, GRACE Guest Faculty
Image
GRACE is very excited to bring you more info from our new program, Supportive Care in Cancer Treatment.

Ramy Sedhom, MD, with Johns Hopkins in Baltimore, Maryland, hosts this episode of Supportive Care in Cancer Treatment. In this video Dr. Sedhom and his guest, Dr. Tyler Stewart with the Moores Cancer Center, UC San Diego, discuss Androgen Deprivation Therapy or ADT for men with prostate cancer.


 

To join the conversation, visit https://cancergrace.org/forum.

To donate to GRACE, visit https://cancergrace.org/donate.

 

 

Video Language

Next Previous link

Previous PostNext Post

Related Content

Online Community

Hi app.92,  Welcome to Grace.  I'm sorry this is late getting to you. And more sorry your mum is going through this.  It's possible this isn't a pancoast tumor even though...

A Brief Tornado.  I love the analogy Dr. Antonoff gave us to describe her presentation.  I felt it earlier too and am looking forward to going back for deeper dive.

Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".

While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".  

I hope any...

My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.

Here's the webinar on YouTube.  It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics

An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:

  1. The antibody, which serves as the “horse,” specifically targets a protein found on cancer...

Recent Comments

JOIN THE CONVERSATION
Hi app.92,  Welcome to Grace…
By JanineT GRACE … on
Webinar OnDemand
By JanineT GRACE … on
My understanding of ADCs is…
By JanineT GRACE … on
Right patient, right time,…
By JanineT GRACE … on